Biomed & Biotech Firms - Publicly Traded*

Cadence Pharmaceuticals Inc.

Company Website

12481 High Bluff Dr. Ste., 200
San Diego, CA 92130

Sourcebook Data

View all the companies in Biomed & Biotech Firms - Publicly Traded*

Cadence Pharmaceuticals Inc.

Market Cap as of 6/12/2015

Market Cap as of 7/03/2014

Market Cap as of 07/02/2013

$590,315,430

Market Cap as of 06/26/2012

$273,299,072

Market Cap as of 01/04/2012

$325,505,200

Market Cap as of 06/20/2011

$577,703,800

Market Cap as of 01/06/2011

$469,837,400

Exchange and Ticker Symbol

Nasdaq: CADX

Fields of Research

Focuses on acquiring, in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting in the United States and Canada

Major Products

Ofirmev

Executives

Theodore Schroeder

  • Chief Executive Officer
  • President